Department of Exercise Sciences, Brigham Young University, Provo, Utah, USA.
Am J Phys Med Rehabil. 2013 Feb;92(2):151-6. doi: 10.1097/PHM.0b013e318269d70a.
The use of near-infrared light in the form of low-level laser therapy (LLLT) has become more popular in the treatment of a variety of conditions where increased peripheral blood flow is desired. The hypothesis behind its working mechanism is its purported ability to generate nitric oxide (NO) in the treated area. We tested the hypothesis that the efficacy of near-infrared light lies in its ability to generate NO at the treatment site.
We conducted a single-blind, placebo-controlled, randomized clinical trial to measure NO, by its metabolites nitrite and nitrate, in venous blood draining from tissue receiving LLLT. Fifteen healthy subjects received LLLT to the forearm, and blood samples were taken immediately before treatment; at 1, 5, 15, and 30 mins; as well as 15 mins after the treatment to check for NO content.
We found a significant treatment effect (F = 15.75, P = 0.003). A post hoc test showed that minutes 1, 5, and 15 were different compared with the baseline measures (P's < 0.05). The area under the treatment curve was significantly larger than the area under the sham treatment curve (t = 2.26, P = 0.037). A limitation of this study was that the data were collected from healthy subjects.
LLLT increased NO levels in venous blood draining from the treatment site in healthy subjects. The peak increase in NO occurred 5 mins into the treatment, after which it slowly waned. Further research is necessary to assess NO increases with LLLT in patients with pathologies.
近红外光以低水平激光疗法(LLLT)的形式在治疗各种需要增加外周血流量的疾病中变得越来越流行。其作用机制背后的假设是它据称能够在治疗区域产生一氧化氮(NO)。我们测试了近红外光的疗效在于其在治疗部位产生 NO 的能力的假设。
我们进行了一项单盲、安慰剂对照、随机临床试验,通过静脉血液中的亚硝酸盐和硝酸盐代谢物来测量接受 LLLT 治疗的组织引流的静脉血液中的 NO。15 名健康受试者接受 LLLT 治疗前臂,在治疗前、治疗后 1、5、15 和 30 分钟以及治疗后 15 分钟采集血样,以检查 NO 含量。
我们发现治疗效果有显著差异(F = 15.75,P = 0.003)。事后检验表明,第 1、5 和 15 分钟与基线测量值不同(P < 0.05)。治疗曲线下面积明显大于假治疗曲线下面积(t = 2.26,P = 0.037)。本研究的一个局限性是数据是从健康受试者中收集的。
LLLT 增加了健康受试者治疗部位引流静脉血液中的 NO 水平。NO 的峰值增加发生在治疗的第 5 分钟,之后缓慢下降。需要进一步研究来评估 LLLT 在患有病理疾病的患者中增加 NO 的情况。